Redhill Biopharma reported $203.67M in Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Biodelivery Sciences International BDSI:US $ 250.33M 8.2M
Cara Therapeutics CARA:US $ 221.45M 28.77M
Cronos Group Inc CRON:CN 1.84B 42.67M
Intra Cellular Therapies ITCI:US $ 625.7M 48.79M
Redhill Biopharma RDHL:US $ 203.67M 16.45M